Clinical Trial Update: A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)

View source ↗

Summary

This is a completed clinical trial evaluating the safety and tolerability of Caelyx in patients with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Caelyx (liposomal doxorubicin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Neoplasm | Status: COMPLETED | Results posted: 2011-07-07